Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2005 Annual Meeting | Using Âé¶¹´«Ã½Ó³»­ Guidelines and Best Current Evidence in Daily Practice

Saturday 04/09/05
02:15 PM - 06:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
PM Half-Day Course
Gary S. Gronseth, MD, FÂé¶¹´«Ã½Ó³»­
Practice Management
Upon completion:
Participants should be able to assess whether any published study provides strong or weak evidence; understand the ways in which methodological quality is assessed for therapeutic, diagnostic, and prognostic studies; understand the diagnostic/prognostic value of transcranial doppler in neurovascular conditions; determine which modalities are effective in treating essential tremor; and understand the prognostic and treatment implications of the presence of a patent foramen ovale in patients with cryptogenic stroke.
No CME available
Advanced
Practitioner, Fellow, Academician, Resident
Event Timeline
02:15 PM - 03:10 PM Translating Best Evidence into Best Practice
Gary S. Gronseth, MD, FÂé¶¹´«Ã½Ó³»­
03:10 PM - 04:00 PM Treating Essential Tremor
Theresa A. Zesiewicz, MD
04:00 PM - 04:20 PM Break
04:20 PM - 05:10 PM The Usefulness of Transcranial Doppler
Michael A. Sloan, MD, MS, FÂé¶¹´«Ã½Ó³»­
05:10 PM - 06:00 PM Prognostic and Treatment Implications of a Patent Foramen Ovale
Steven R. Messe, MD, FAHA, FÂé¶¹´«Ã½Ó³»­
Faculty Disclosures
Gary S. Gronseth, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with Âé¶¹´«Ã½Ó³»­.
Michael A. Sloan, MD, MS, FÂé¶¹´«Ã½Ó³»­ No disclosure on file
Steven R. Messe, MD, FAHA, FÂé¶¹´«Ã½Ó³»­ Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.